Replies to post #8877 on Soligenix Inc (SNGX)

[Maps0117]

Homeland Security News Wire

The adjuvant-free formulation of RiVax induced toxin neutralizing antibodies that lasted up to 127 days after the third vaccination in several individuals.

By employing ThermoVax during the final formulation of RiVax, the vaccine has demonstrated enhanced stability and the ability to withstand temperatures at least as high as 40 degrees Celsius (104 degrees Fahrenheit) for up to one year.

http://www.homelandsecuritynewswire.com/dr20180713-soligenix-receives-european-canadian-patents-for-its-ricin-toxin-vaccine-rivax-formulation?page=0,1